However, our curriculum and platform were ready to perform. We expanded trainings to meet the demand and scaled up our platform to serve doctors and patients now in need of a safe way to give and receive care.
Our quick turn, allowing continuation of care through safe and well-developed technology, came as a result of preparation. Investing in innovation is key. COVID-19 proved this is just as true for primary care as it is for recognized high tech fields like neurosurgery.
Reason 2: Reimbursement for telemedicine
Responsibility for the slow advent of telemedicine is often laid at the door of reimbursement rules. As of 2019, the Centers for Medicare and Medicaid Services (CMS) had not made consultations via phone or internet billable transactions.
Again, the cascading effects of COVID-19 ushered in a series of Emergency Orders. One of these orders made telemedicine consultations billable or reimbursable transactions. Private payers followed Medicare and Medicaid in making this change.
The update in public policy shed sunlight on the seedling of telemedicine. We now have a much stronger place in the industry and based on approval of both physician and patient participants are likely to continue to grow.